Filling the “GAP” in Real-World Assessment of Psoriatic Arthritis Disease Activity: Performance Characteristics of a Global/Pain Composite Endpoint-Reference-Cited by-同舟云学术

Filling the “GAP” in Real-World Assessment of Psoriatic Arthritis Disease Activity: Performance Characteristics of a Global/Pain Composite Endpoint

Published:2024-07-02 Issue: Volume: Page:
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Tillett William^ORCID,Birt Julie^ORCID,Vadhariya Aisha^ORCID,Ross Sarah,Ngantcha Marcus,Ng Khai Jing^ORCID

Funder

Eli Lilly and Company

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40744-024-00690-1.pdf

Reference37 articles.

1. Helliwell PS, FitzGerald O, Fransen J, et al. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Ann Rheum Dis. 2013;72:986–91. https://doi.org/10.1136/annrheumdis-2012-201341.

2. Mumtaz A, Gallagher P, Kirby B, et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis. 2011;70:272–7. https://doi.org/10.1136/ard.2010.129379.

3. Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker E, Smolen JS. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis. 2010;69:1441–7. https://doi.org/10.1136/ard.2009.122259.

4. Smolen JS, Schoels M, Aletaha D. Disease activity and response assessment in psoriatic arthritis using the Disease Activity Index For Psoriatic Arthritis (DAPSA). A brief review. Clin Exp Rheumatol. 2015;33(93):S48–50.

5. Coates LC, Fransen J, Helliwell PJ. Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment. Ann Rheum Dis. 2010;69:48–53. https://doi.org/10.1136/ard.2008.102053.